Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2005
10/25/2005US6958346 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
10/25/2005US6958345 syn-N1-(2-hydroxymethylcyclopropylidenemethyl)-cytosine for example; treating HIV, herpes viruses, Epstein-Barr virus (EBV), hepatitis B virus
10/25/2005US6958344 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/25/2005US6958332 Treating an interleukin-12 overproduction-related disorder; treating rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005US6958319 Stability and longer shelf life; bortezomib N-(2-pyrazine)carbonyl-L-phenylalanine-L-leucine boronic acid
10/25/2005US6958145 Synthesis of cyclic compounds
10/25/2005CA2359708C Ketolide antibiotics
10/25/2005CA2185470C Compositions and methods for vaccines comprising .alpha.-galactosyl epitopes
10/20/2005WO2005097976A1 Dendritic cell obtained by antigen pulsing
10/20/2005WO2005097822A1 Identification of the precise amino acid sequence of the epitope recognized by the potent neutralizing human anti-hiv-1 monoclonal antibody igg1b12
10/20/2005WO2005097814A2 Composition and method for inhibiting platelet aggregation
10/20/2005WO2005097803A1 Novel water-soluble prodrug
10/20/2005WO2005097152A1 Turmeric extract-containing composition having improved caking capacity
10/20/2005WO2005097148A1 Pharmaceutics of traditional chinese medicine of treating aids and preparation method thereof
10/20/2005WO2005097094A1 Antimicrobial compositions and methods for their use
10/20/2005WO2005096836A1 Sinapic acid supplementation
10/20/2005WO2005096806A1 Rice plant having vaccine gene transferred thereinto
10/20/2005WO2004028481A3 Nucleoside derivatives for treating hepatitis c virus infection
10/20/2005WO2003106413A3 Process for the preparation of oxazolidinones and method of use thereof
10/20/2005WO2002097033A3 Antibodies that immunospecifically bind to trail receptors
10/20/2005US20050234233 Cephalosporins
10/20/2005US20050234133 Use of fingolimod or salt
10/20/2005US20050234118 Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/20/2005US20050234117 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level
10/20/2005US20050234116 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia
10/20/2005US20050234089 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
10/20/2005US20050234088 Urea substituted imidazoquinoline ethers
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234077 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005US20050234052 Treatment for ocular infections
10/20/2005US20050234047 Respiratory syncytial virus replication inhibitors
10/20/2005US20050234045 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
10/20/2005US20050234041 Substituted 1-benzazepines and derivatives thereof
10/20/2005US20050234035 New salts
10/20/2005US20050234032 Antibacterial compositions comprising metal phthalocyanine analogues
10/20/2005US20050234029 Compounds
10/20/2005US20050234017 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
10/20/2005US20050234011 Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050233408 Modified bacterial surface layer proteins
10/20/2005US20050233396 an assay method of infecting cultured cells with vaccinia virus;co-transfecting the cells with plasmids of DNA encoding the I7L protease enzyme such that both the substrate protein and enzyme are expressed; then measuring cleaved I7L protease
10/20/2005US20050233349 Crystal structure of ribosomal protein L11/GTPase activating region rRNA and uses thereof
10/20/2005US20050233328 Methods of identifying compounds that modulate protein activity
10/20/2005US20050232950 Viruses comprising mutant ion channel protein
10/20/2005US20050232947 Bacterial spores
10/20/2005US20050232946 Vaccine against microbial pathogens
10/20/2005US20050232945 Anti-viral agents prepared from sea lettuce as raw material
10/20/2005US20050232943 Antigenic composition of a Pseudomonas aeruginosa protein
10/20/2005US20050232942 Virulence genes, proteins, and their use
10/20/2005US20050232938 Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
10/20/2005US20050232937 Paramycobacterial diagnostics and vaccines
10/20/2005US20050232936 Meningococcus adhesins nada, app and orf 40
10/20/2005US20050232932 Compositions and methods for dendritic cell-based immunotherapy
10/20/2005US20050232898 Stabilized protein compositions
10/20/2005US20050232879 Antifungal medicinal compositions
10/20/2005CA2799469A1 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
10/20/2005CA2563502A1 Novel water-soluble prodrug
10/20/2005CA2562385A1 Identification of the precise amino acid sequence of the epitope recognized by the potent neutralizing human anti-hiv-1 monoclonal antibody igg1b12
10/20/2005CA2562004A1 Sinapic acid supplementation
10/20/2005CA2561958A1 Composition and method for inhibiting platelet aggregation
10/20/2005CA2561876A1 Antimicrobial compositions and methods for their use
10/20/2005CA2558829A1 Methods for treating viral infection using il-28 and il-29 cysteine mutants
10/20/2005CA2558817A1 Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
10/19/2005EP1586646A2 Lawsonia intracellularis vaccine
10/19/2005EP1586582A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
10/19/2005EP1586580A2 Process for the purification of daptomycin
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1586322A2 Compositions for inhibition of anglogenesis
10/19/2005EP1585805A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
10/19/2005EP1585764A2 Rantes-derived peptides with anti-hiv activity
10/19/2005EP1585757A2 Peptide deformylase inhibitors
10/19/2005EP1585753A2 Novel semisynthetic macrolide antibiotics of the azalide series
10/19/2005EP1585752A1 Polyene polyketides, processes for their production and their use as a pharmaceutical
10/19/2005EP1585713A1 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists
10/19/2005EP1585545A2 Methods of inducing and maintaining immune tolerance
10/19/2005EP1585529A2 Process for the production of 2'-branched nucleosides
10/19/2005EP1585497A1 Mastitis treatment
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1438333A4 Anti-fusion assay
10/19/2005EP1404656B9 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
10/19/2005EP1345616A4 Reducing cellular damage in the human body
10/19/2005EP1339415A4 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP1254131B1 Extraction of flavonoids
10/19/2005EP1198249B1 Use of cpg as an adjuvant for hiv vaccine
10/19/2005EP1185712B8 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
10/19/2005EP1016406B1 Ophthalmic compositions for soft contact lens comprising terpenoid
10/19/2005EP1002054B1 Process for the production of virus in cell cultures
10/19/2005EP1000163B1 Pseudomonas exotoxin a-like chimeric immunogens
10/19/2005EP0882132B1 A human cytomegalovirus combined antigen and its use
10/19/2005EP0768894B1 Multi-stage cascade boosting vaccine
10/19/2005CN1685063A Methods and compositions relating to gene silencing
10/19/2005CN1684966A Novel adenine compound and use thereof
1 ... 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 ... 1798